Recurrent Small Cell Lung Cancer (SCLC) Active Not Recruiting Phase 2 Trials for Topotecan (DB01030)

Also known as: Recurrent Small-cell Lung Cancer (SCLC) / Small Cell Lung Cancer Recurrent / Refractory Small cell lung cancer / Recurrent Small Cell Lung Cancer / Recurrent Lung Small Cell Carcinoma / Recurrent Small Cell Lung Carcinoma

IndicationStatusPhase
DBCOND0122754 (Recurrent Small Cell Lung Cancer (SCLC))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03896503Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the LungsTreatment